DawgTalkers.net Forums DawgTalk Everything Else... Covid-19: Again

Some positive news, from Italy no less.

https://www.bbc.com/news/world-europe-54356335

Found out I was in contact with COVID positive patients last week. I was not made aware of their status until today. I thankfully had my monthly COVID test done on Monday. I’m awaiting results.
I treat everyone I come in contact with, besides my girlfriend, as though they are positive. At work I’m crazy diligent about my PPE. Coming home from seeing clients I strip in the garage... etc.
It’s all getting really old, fast. I miss my life, my career, before all this.
I know for the average person, that this may effect directly very little, it must seem like such a bore by now. I really do understand this.
But I don’t get a break. I don’t get to let my guard down.
Please stay diligent. If not for you, do it for the rest of us schlubs that have no choice but to face it.

Plea/rant over.

Hope it comes back negative.
How long is it taking to get results these days?

I expect with flu season starting soon, that we will begin seeing an upward trend in infections again very soon.

Or if we are lucky, all the sniffling, sneezing, coughing people will entice more people to mask up.

I’m hoping my result will be in today. We got our results back in two days last time. The lab must be busier this time around.
I don’t normally get a flu shot. I’ll be getting one next week. Anything I can do to boost my immune system for the coming winter I’ll take. My hope is mask wearing and social distancing will keep the flu numbers down this year.

I've had to take a couple tests, and I've seen the CVS do-it-yourself test come back earlier than estimated, while the "brain poke" at urgent care took MUCH longer.

Thinking about you and hoping you get a good result.

Very useful graphic I saw today:

.


Edit: Larger, easier to read version, but messes up formatting here:

https://pbs.twimg.com/media/EjToVjMXgAIjfsL?format=jpg&name=4096x4096

Thank you for that.

Praying for you buddy.

Hoping for the best for you. I know this must be very hard on you having no real break from what the rest of us deal with on the daily. In comparison, most of us don't have to live it most every hour of every day.

Looks like the rates/percentages have held steady since the onset of things. With the exception of actually have a percentage for asymptomatics, the rest seem to be just about exactly what we we talking about back in March.

Coronavirus vaccine trial participants report day-long exhaustion, fever and headaches — but say it’s worth it

KEY POINTS

• High fever, body aches, headaches and exhaustion are some of the symptoms participants in Moderna and Pfizer’s coronavirus vaccine trials say they felt after receiving the shots.
• While the symptoms were uncomfortable, and at times intense, they often went away after a day, sometimes less.
• The phase three trials are a critical last step needed to get the vaccines cleared for distribution.

Luke Hutchison woke up in the middle of the night with chills and a fever after taking the Covid-19 booster shot in Moderna’s vaccine trial. Another coronavirus vaccine trial participant, testing Pfizer’s candidate, similarly woke up with chills, shaking so hard he cracked a tooth after taking the second dose.

High fever, body aches, bad headaches and exhaustion are just some of the symptoms five participants in two of the leading coronavirus vaccine trials say they felt after receiving the shots.

In interviews, all five participants — three in Moderna’s study and two in Pfizer’s late-stage trials — said they think the discomfort is worth it to protect themselves against the coronavirus. Four of them asked not to be identified, but CNBC reviewed documentation that verified their participation in the trials.

While the symptoms were uncomfortable, and at times intense, they often went away after a day, sometimes sooner, according to three participants in the Moderna trial and one in Pfizer’s as well as a person close to another participant in Moderna’s trial.

The phase three trials are a critical last step needed to get the vaccines cleared for distribution. At least 41 Covid-19 vaccines are in human trials worldwide but only four U.S.-backed candidates are in phase three: Moderna, Pfizer, AstraZeneca and Johnson & Johnson. Health officials expect to have at least one safe and effective vaccine by the end of the year.

Double-blind

The trials, which each have tens of thousands of participants, are double-blind, meaning half of them are receiving saline or another placebo and patients don’t know what treatment they are receiving. The health care worker administering the vaccine is also in the dark. While it’s possible some of the symptoms described could be attributed to an unrelated illness, Moderna and Pfizer previously said some participants in their phase one trials experienced mild Covid-19 symptoms. But Pfizer said it was in a minority of its cases. The trials are also still ongoing, so it remains to be seen how many participants who received the vaccine will report side effects.

Hutchison, a 44-year-old computational biologist in Utah, said he signed up for Moderna’s phase three trial because he’s healthy, physically fit and a big believer in vaccines. He specifically wanted to support Moderna’s effort, as he was intrigued by the company’s RNA-based approach. While still experimental, mRNA vaccines potentially offer faster development and production times, which could be a major benefit during a global pandemic that has led to more than 1 million fatalities.

“I had a high degree of confidence it would work and I wanted to contribute to the solution,” Hutchison said.

Bed bound

After getting the first shot on Aug. 18, he said he felt a little under the weather for several days with a low-grade fever. He got his second shot at a clinic on Sept. 15. Eight hours later, he said he was bed bound with a fever of over 101, shakes, chills, a pounding headache and shortness of breath. He said the pain in his arm, where he received the shot, felt like a “goose egg on my shoulder.” He hardly slept that night, recording that his temperature was higher than 100 degrees for five hours.

After 12 hours, Hutchison said he felt back to normal and his energy levels returned. Having signed a lengthy consent form, Hutchison was aware that he might experience symptoms. But he was still struck by the severity and duration, tweeting on Sept. 16 that he experienced “full on Covid-like symptoms.”

Two other participants in the Moderna trial, who asked to remain confidential because they feared backlash from the company, reported similar side effects. Likewise, one participant in the Pfizer trial said he experienced more severe symptoms than he expected.

Moderna and Pfizer have acknowledged that their vaccines could induce side effects that are similar to symptoms associated with mild Covid-19, such as muscle pain, chills and headache. As companies progressed through clinical trials, several vaccine makers abandoned their highest doses following reports of more severe reactions.

Infectious disease specialist Florian Krammer of New York’s Mount Sinai said on Twitter that the side effects reported in Moderna’s phase one trial are “unpleasant but not dangerous.” It remains to be seen whether kids and pregnant women will experience similar symptoms.

Short-term pain

If approved, the Covid-19 vaccine would not be the first to cause short-term pain and discomfort in some recipients. “It’s a simple fact that some vaccines are more unpleasant to take than others,” Stat News’ Helen Branswell recently wrote.

One North Carolina woman in the Moderna study who is in her 50s said she didn’t experience a fever but suffered a bad migraine that left her drained for a day and unable to focus. She said she woke up the next day feeling better after taking Excedrin, but added that Moderna may need to tell people to take a day off after a second dose.

She said other people in the trial have joined a couple of private Facebook groups and have shared similar experiences. She said members of the groups also reported a fever and pain in the arm similar to getting a tetanus shot, adding “you’re not going to be lifting weights or working out.”

“If this proves to work, people are going to have to toughen up,” she said. “The first dose is no big deal. And then the second dose will definitely put you down for the day for sure. ... You will need to take a day off after the second dose.”

Worth the risk

She said while uncomfortable, the apparent side effects are worth the risk of not getting Covid-19. “My hope is that this works but also that the communication [on side effects] is good,” she added.

A Maryland participant in his late 20s said he experienced nausea after the first shot, but it wasn’t until the second that he “really felt things.”

He said he woke up at 1 a.m. with chills and a 104 fever. He said the fever went down after he took Advil and Tylenol but it lasted until around 8 p.m. He said Moderna promptly responded, calling him within an hour after he reported his symptoms in the app.

“I wasn’t sure if I needed to go to the hospital or not because 104 is pretty high,” he said. “But other than that, it’s been fine.”

Side effects

Pfizer’s phase one study showed “short-lived fever, mostly mild to moderate in severity, can be expected in a minority of recipients of BNT162b2 30mcg,” spokeswoman Jerica Pitts said.

“No safety signals have been identified in the study,” Pitts said in an email. “As discussed earlier, safety and tolerability of our vaccine candidate are continuously monitored by Pfizer qualified personnel and a DMC, an independent external data monitoring committee, which has access to unblinded data.”

A Moderna spokeswoman said the company does not comment on participants in ongoing clinical trials, but added that the safety committee “has recommended that the study continue as planned” at each review.

A spokesperson from the National Institute of Allergy and Infectious Diseases, which is helping to develop Moderna’s vaccine, declined to comment and referred CNBC to a press release and Q&A for information about how participant safety is being monitored. The NIAID is not involved with the Pfizer trial.

‘Educating the public’

Hutchison said he’s concerned that the pharmaceutical manufacturers have not sufficiently informed the public about potential side effects. If the vaccines are approved, he fears, it might cause a widespread backlash if word spreads, which is why he decided to go public now. Polls show some 35% of Americans say they won’t get a coronavirus vaccine when it is available, because of misinformation or mistrust.

The White House has dubbed its project to bring a vaccine to market in record time as “Operation Warp Speed,” which has raised concern that drugmakers may take shortcuts to produce one quickly. President Donald Trump’s push to have a vaccine ready before the Nov. 3 election also isn’t helping to allay those fears. The pharmaceutical companies tried to tamp down those doubts by releasing a joint statement in September that pledged to “stand with science,” rather than politics, saying the clinical trials won’t sacrifice safety or the effectiveness of a vaccine.

Kolina Koltai, a vaccine researcher at the University of Washington at the Center for an Informed Public, said using “speed” to describe a national vaccine campaign can be counterproductive, even if the trials are robust.

“I’m hearing from people who say they want other people to test it (the vaccine) first,” she said. “There’s a lot of uncertainty.”

Young people

Another challenge with the vaccine is that young people, who don’t tend to get as sick as people over 40, may not think they are at high risk for severe health outcomes if they get the virus. If they hear about side effects via word of mouth, they may not deem the vaccine to be worth it.

The vaccine is “fairly unusual,” said Dr. Peter Bach, an epidemiologist and director of the Center for Health Policy and Outcomes at Memorial Sloan-Kettering, because the benefits to some young and healthy groups may be “secondary” in nature.

In order words, getting a coronavirus vaccine — like wearing a mask — may be an act of service to help protect others. But public health officials can have difficulty getting some people to wear a mask, indicating that even more people may be reluctant to get the vaccine.

Hutchison is continuing to report his symptoms via an app, which serves as a form of a diary. He has returned to the clinic for follow-up visits on several occasions, including after he received the second dose.

Since tweeting about his experience, Hutchison said he has received pushback from people who felt that he shouldn’t have said he received the vaccine rather than the placebo. Given his symptoms, he said he thinks it’s highly unlikely he was part of the control group that received a saltwater solution.

Up all night

A physician in Baltimore participating in the Pfizer study is due for his second dose on Saturday. While he said his symptoms were “very mild” for the first dose, he wouldn’t be surprised if others experienced symptoms more serious than a flu shot and said people should be prepared for that.

Another participant in Pfizer’s trial said he was up all night after the first shot from the pain of the injection. The booster injection he received caused more of that same pain in his arm, followed by intense flu-like symptoms that hit him around 1a.m. He couldn’t sleep that night without an electric blanket, and shook so hard that it became uncontrollable and he cracked part of his tooth from chattering them.

“It hurt to even just lay in my bed sheet,” he said, before he decided to see a doctor.

Despite all that, he remains pro-vaccine and said he is a big advocate for science. Had he known in advance, he would have recommended getting the shot on a Friday so he could rest on the weekend. He recognizes that getting the virus would likely still be far worse for many people.

“If it gets approved, I still think a lot of people should get the vaccine,” he said, “and I hope that all the side effects are made clear upfront.”

https://www.cnbc.com/2020/10/01/coronavi...-headaches.html

Double posted for those who don't go to PP.

jc

Spam calls hindering efforts for contact tracing.

I definetly had all of those symptoms 2+ years ago.

Especially the all awful chill shaking during the fever,(teeth chattering) My Gosh! my gosh! remembered, childhood swimming in very cold swimming pool and teeth would chatter, and telling about how this flu I had was like that, for up to 4 days , it would hit, and I'd take deep breaths, severe heart burn, accelerated heart rate, afraid to fall asleep, drinking water to try and calm it down, (and before January of 2019) 4 days, shook so bad, got so cold, had a very hot forehead, at the end I finaly took my temperature after days, and the return to normal temp was very low, 94 something.

If I've had this stuff once or twice before, I don't want to take a vaccine to give it another go round, s-c-r-e-w That! not again, no way, too dangerous. fudge.

mRNA vaccines holds a ton of promise.

Jester or Portland, have either of you read up on mRNA tech? I thought I read somewhere that this type of a vaccine could open up pathways to cures and treatments for other conditions besides viral infections.

Here's my reply to another post of this same article. Unless these questions can be answered, it's nothing more than a sensationalized attempt at scaring people.

Maybe they will make a serious attempt to deal with spam calls now.

There is no reason in this day and age to be soliciting anything over the phone, unless your a scammer.

The robo calls are getting ridiculous, and lately they have been showing that number as the same area code and prefix as my phone, making one wonder if it is someone you know.

mRNA technology is really new, very promising, and seemingly has no ceiling.

Besides vaccines, theoretically we can come up with cures for cancer, crohn's dse, lupus and other things that have an immunologic basis. Thinking even further out, I don't see why we couldn't use it to find a way to fight heart disease.

But despite how promising it is, it is very young. Anyone who has been in medicine for any extended amount of time (probably true for any industry) has seen new drugs, new modalities, no approaches to doing things that are really exciting because of how promising the early data looks only have them fail miserably. To date, there has been no human vaccine or medication developed using this technology.

Here is an article I found that is pretty informative without being overly scientific.


Five things you need to know about: mRNA vaccines
01 April 2020


According to Prof. Bekeredjian-Ding, an approved mRNA coronavirus vaccine would be easier and faster to produce and thus deploy worldwide than a conventional vaccine. Image credit - Unsplash/Liliya Lisa
The race for a vaccine against the novel coronavirus, or SARS-CoV-2, is on, with 54 different vaccines under development, two of which are already being tested in humans, according to the World Health Organization. And among the different candidates is a new player on the scene – mRNA vaccines.

One mRNA vaccine developed by US company Moderna began its first human trials on 16 March, whereas another under development by German company CureVac has been offered €80 million in investment by the European Commission. But what exactly are mRNA vaccines and why could they be promising in the fight against the coronavirus? We spoke to Professor Isabelle Bekeredjian-Ding, head of the microbiology division of Germany’s Paul Ehrlich Institut, which provides scientific advice to companies, including CureVac, and who sits on the scientific committee of Europe's Innovative Medicines Initiative. Here are five things to know.

If an mRNA vaccine was approved for coronavirus, it would be the first of its type. ‘It's a very unique way of making a vaccine and, so far, no (such) vaccine has been licenced for infectious disease,’ said Prof. Bekeredjian-Ding.

Vaccines work by training the body to recognise and respond to the proteins produced by disease-causing organisms, such as a virus or bacteria. Traditional vaccines are made up of small or inactivated doses of the whole disease-causing organism, or the proteins that it produces, which are introduced into the body to provoke the immune system into mounting a response.

mRNA vaccines, in contrast, trick the body into producing some of the viral proteins itself. They work by using mRNA, or messenger RNA, which is the molecule that essentially puts DNA instructions into action. Inside a cell, mRNA is used as a template to build a protein. ‘An mRNA is basically like a pre-form of a protein and its (sequence encodes) what the protein is basically made of later on,’ said Prof. Bekeredjian-Ding.

To produce an mRNA vaccine, scientists produce a synthetic version of the mRNA that a virus uses to build its infectious proteins. This mRNA is delivered into the human body, whose cells read it as instructions to build that viral protein, and therefore create some of the virus’s molecules themselves. These proteins are solitary, so they do not assemble to form a virus. The immune system then detects these viral proteins and starts to produce a defensive response to them.

2. They could be more potent and straightforward to produce than traditional vaccines

There are two parts to our immune system: innate (the defences we’re born with) and acquired (which we develop as we come into contact with pathogens). Classical vaccine molecules usually only work with the acquired immune system and the innate immune system is activated by another ingredient, called an adjuvant. Interestingly, mRNA in vaccines could also trigger the innate immune system, providing an extra layer of defence without the need to add adjuvants.

‘All kinds of innate immune cells are being activated by the mRNA,’ said Prof. Bekeredjian-Ding. ‘This primes the immune system to get prepared for an endangering pathogen and thus the type of immune response that is triggered is very strong.’

There is still a lot of work to be done to understand this response, the length of the protection it could give and whether there are any downsides.

Prof. Bekeredjian-Ding also explains that because you’re not introducing the whole virus into the body, the virus can’t mount its own self-defence and so the immune system can concentrate on creating a response to the viral proteins without interference by the virus.

And by getting the human body to produce the viral proteins itself, mRNA vaccines cut out some of the manufacturing process and should be easier and quicker to produce than traditional vaccines. ‘In this situation, the major benefit is that it's easy to produce (and) it will also probably be relatively easy to do an upscaling of production, which of course, is very important if you think about deployment throughout Europe and the world,’ said Prof. Bekeredjian-Ding.


‘It's a very unique way of making a vaccine and, so far, no (such) vaccine has been licenced for infectious disease.’

Prof. Isabelle Bekeredjian-Ding, Paul Ehrlich Institut, Germany


3. Most of what we know about mRNA vaccines comes from work on cancer

Most work on using mRNA to provoke an immune response has so far been focused on cancer, with tumour mRNA being used to help people’s immune systems recognise and respond to the proteins produced by their specific tumours. ‘This technology was very good for the oncology field, because you can develop patient-specific vaccines because every tumour is different,’ said Prof. Bekeredjian-Ding.

Using tumour mRNA in this way activates the body’s T-cells – the part of the acquired immune system that kills cells, which is useful to destroy tumours. It could be important for coronavirus, too. ‘In viral infections, often we know that there is a need for a strong T-cell response because viruses like to hide in cells,’ said Prof. Bekeredjian-Ding. ‘There is a certain hope that, especially in this setting, this could really work … and thereby eliminate … the infected cells from the body.’

But to combat a virus such as SARS-CoV-2, it is likely that a different part of the acquired immune system also needs to be activated – the B cells, which produce antibodies that mark the virus out for destruction by the body. ‘And there is little experience with this (apart from animal infection models), because for the tumour model this was not that relevant.’

4. There are a lot of unknowns

Because mRNA vaccines are only now beginning to be tested in humans, there are a lot of fairly basic unknowns which can only be answered through human trials. ‘What is really the current challenge, I think, is to understand whether these vaccines will really be able to mount a sufficiently protective immune response in the human and to understand, for example, which quantities of mRNA will be needed to do this,’ said Prof. Bekeredjian-Ding.

Other outstanding questions include whether the proteins that have been chosen for the vaccine are the right ones to prevent a coronavirus infection in the body, how targeted the immune response is to this particular coronavirus, how long any immunity would last, and whether it causes side-effects such as increased inflammatory responses like redness and swelling or, in the worst case, aggravates disease.

5. It would be possible to vaccinate on a large scale.

Once an mRNA vaccine has been approved, which could take 12-18 months, it should be easy to scale up production. Because the manufacturing process is shorter than for other vaccines – Prof. Bekeredjian-Ding estimates a few months rather than 1-2 years for conventional vaccines – there is potential for these vaccines to be scaled up quickly. This is useful in the context of coronavirus, which will likely need mass immunisation programmes.

‘I think we will need a very high population coverage, but it depends a little bit on the countries and the epidemiology,’ said Prof. Bekeredjian-Ding. ‘In the countries where coronavirus has been spreading very fast, we also expect that there's many people who have been in contact with the virus and who have actually mounted a natural immune response. But on the other hand, if you look at Germany, for example, right now we're all at home, barred, and not allowed to leave the house except for necessities.

The population therefore remains susceptible to infection, she says. ‘And so here, you would definitely need to think about vaccinating the whole population.

‘That’s why also these vaccines are of interest, because you could probably manage that, while, with other vaccines, it's harder to produce these quantities (in a short period of time).’



https://horizon-magazine.eu/article/five-things-you-need-know-about-mrna-vaccines.html

Really amazing what they've done in medicine over the last 40-50 years, and the future will probably bring so many more amazing treatments and cures.

If it's important, they'll leave a message.

That is my attitude.

I am a old guy. To me, answering the phone is an option. I was probably around 42 or more before I had a cell phone.

If I don't know the number, I ignore it. Just like the old days, if the phone rings while I am doing something, I don't stop what I am doing to answer the darn phone unless I am expecting a call.

They will call back if it is important.

That's a nice thing about caller i.d. on a land line, or just a cell phone. If it's someone I know, I'll answer, generally. (cell phone, that is).

I won't answer if I'm driving though, because with my hearing loss, I wouldn't be able to understand them. I figure it's better if they leave a message that I can listen to when I'm not driving and call them back. As opposed to constantly saying "what?"

Just wanting to give a little update on the Covid situation.

Some of you know that I live in Charlotte NC. The hospital I work at is a medium sized community hospital about 20 west of Charlotte. In the spring, we peaked out with about 40 covid + patients in the hospital at any one time. About 8 weeks ago we were down to 12 (the lowest we have been since this started). Today, we are up to 64.

The 2 main hospitals in Charlotte, one is about our size, the other 50-70% bigger, have fewer covid + patients combined than we do. I think the difference is that in Charlotte and Mecklenburg county the state mask mandate is being followed and enforced. My hospital is in the next county over where people are refusing to wear masks and businesses are not enforcing it.


My thoughts on the vaccine.
A couple have had some recent setbacks.I am not encouraged a vaccine is going to be the answer in the near future. There are still safety questions that need to be answered and how well they work is still in question. Will we need annual covid vaccinations? Twice a year? Quarterly?

Then, even if we have one that is determined to be safe and effective, about half of the most promising ones need to be stored at incredibly low temperatures. You won't be able to get those at your doctor's office. There are going to have to be Covid Vaccination Centers. To get a vaccine approved, produced, distributed across the country and people vaccinated is going to take months. April, May, June of 2021 would be optimistic.

What I think we need is a medication like tamiflu. Tamiflu is an antiviral pill that treats the flu. If you have the flu your doctor can call it into your pharmacy. We need something like that for covid. Right now, if you get covid all I can tell you to do is check your temps and monitor your oxygen levels and if your oxygen levels fall go to the hospital. That's because we have no medications to treat covid as an outpatient. We have some so-so therapies once you get bad enough to be admitted.

Merck has been working on a new drug to treat the flu. Is studying it, they found that it has activity against the coronavirus that caused the original SARS back in 2002 and against MERS in 2012. They are investigating its activity against covid.

To me that will be the game changer. You get diagnosed with covid and we give you this medication by pill to keep you out of the hospital.

j/c

At least 30 states report daily increase in COVID-19 cases

https://abcnews.go.com/GMA/News/video/30-states-report-daily-increase-covid-19-cases-73547062

Regeneron showed promise before all the PR hype but that's expensive and needs more data.

Here's to hoping that can eventually be mass produced at a cheap cost to everyone.

But unlikely to be available widespread for outpatient usage. You will need to be hospitalized to get it.

I gotta bad feeling about this-

GC. The shutdown mask message is becoming like the Iraq war, let me explain.

In 2003 ish, The USA invaded Iraq, and bad times moved on.

Somewhere in the following two years ish, 3 separate times I heard this message,
Somebody, congress the administration, somebody, (it was supposed to be a good message, and it was a daytime news story)
Iraq war.

"Somebody, has decided to cut troop deployments from 24 months to 18 months." (it may have been 18-12, my memory, what I am sure of is it was the SAME NUMBER, all 3 times)

Then Several weeks later, may have been 3 months, may have been most of a year, later,

A 2nd time, same story, same exact message, supposed to be good news, a daytime news story
"Somebody has decided to cut troop deployments from 24 months to 18 months"
THE EXACT SAME NUMBER OF MONTHS, so nothing had improved, a false narrative of a good news story.

Then a 3rd time, SEVERAL WEEKS LATER, may have been 2 and a half, or 3 months, may have been most of a year later,
same exact message,

"Somebody has decided to cut troop deployments from 24 months to 18 months."
The EXACT SAME NUMBER OF MONTHS, A 3RD TIME, so nothing had improved, a false narrative of a good news story.

Covid

has become like this,
We are getting the same message on, mask wearing, and shutdowns.

String everybody along until the masses are starving like Venezuela, or Cuba, or North Korea, or take your pick.

I'm glad you're not a doctor.

Muh mechanic is going to do my brain surgery right after he finishes this brake job...

You know the difference between an Engine Mechanic and a Heart Surgeon right?









Heart Surgeon does his job while the motor is still running.

GC.

Dawgtalkers first topics, thread titles list.

Advanced Net gen. stats.

Braves

Covid 19 again,

New Research explores

Survivor Pool

How many lost.
________



Just saying.

Anybody have that picture where it was 3rd and 4, score 34-34, with 3:40 to go in the 3rd.
on the 34 yard line.

Pssst....

It's not actually "Covid 19 again". It's still Covid 19.

Hospitalizations Surge Anew As COVID Cases Rise In 39 States

https://khn.org/morning-breakout/hospitalizations-surge-anew-as-covid-cases-rise-in-39-states/

So, it's going exactly as the experts told us it probably would?

Yes. When you follow guidelines it goes down. When you start ignoring those guidelines the numbers go up.

Cuyahoga County, 28 other Ohio counties now under red alert for coronavirus

https://www.cleveland.com/coronavirus/20...source=facebook

Again, it's doing exactly what we were told it would. Guidelines or not. Same in Europe. And Asia. https://www.worldometers.info/coronavirus/#countries

https://www.worldometers.info/coronavirus/#countries


On a personal note: My niece was exposed. Had to quarantine. Her college room mate had it. She's fine. My nephew, a twin, was exposed, had to quarantine. His twin, which, get this, he lives with, didn't, neither did his mom, my sister, or his dad, my bil.

2 friends had it, they're fine. Mid 50's. My cousin and his wife, late 40's had it. Gave it to my aunt (his mom 76 years old), all are fine. My uncle didn't get it, cousins kids didn't get it.

Sis in law had it, She's 59 or 60. She's fine. Her husband, my brother, didn't get it, and neither did the 2 semi adopted kids they have.






Hey, some of us can't stay locked up in our houses forever, or even a year. Read today that 8 million americans have become poor/homeless because they can't work. Many more could work, but won't.

Guidelines are good, but not fool proof. I wear a mask when I'm out and about. Don't have a problem doing it.

But it's doing exactly what we were told it would do. Spread, and it will continue to do so, regardless of guidelines.